The invention belongs to the technical field of functional foods and medicines, and particularly discloses application of L-
selenium methyl selenocysteine in preparation of a product for targeted regulation of intestinal
flora to relieve
chemotherapy immune injury. The target regulation is realized by specifically improving the relative abundance of the
beneficial bacteria, namely,
Bacteroides acdifaciens, in the intestinal tracts of the subject, so that the relative abundance of the
beneficial bacteria, namely the
Bacteroides acdifaciens, in the intestinal tracts of the subject is improved. Systematic contrast experiments prove that under the condition of equal
selenium content, the
selenium-enriched milk
powder strengthened by taking L-selenium
methyl selenocysteine as a unique selenium source has the effect obviously superior to that of contrast milk
powder strengthened by selenium-enriched
yeast or
sodium selenite in the aspect of relieving
immunosuppression,
intestinal injury and
systemic inflammation caused by
cyclophosphamide. The core mechanism of the L-selenium
methyl selenocysteine is that the L-selenium methyl
selenocysteine can be used for efficiently and specifically enriching
Bacteroides acdifaciens, and the L-selenium methyl
selenocysteine can be used for efficiently and specifically enriching Bacteroides acdifaciens. Based on the discovery, the invention correspondingly provides a selenium-enriched milk
powder product with definite targeting property and excellent effects, and a brand new efficient solution is provided for
chemotherapy auxiliary
nutrition support of tumor patients.